Search research articles
Contact Us
Filters
Showing results (1-10 of 164) with videos related to
Page
of 17
Sort By:
Oncology (Williston Park, N.Y.)
|
March 28, 2009
Toward evidence-based management of the dermatologic effects of EGFR inhibitors
Patricia LoRusso
Targeted Oncology
|
May 7, 2011
Targeting phosphatidylinositol 3 kinase (PI3K)-Akt beyond rapalogs
Shin Ogita, Patricia Lorusso
Therapeutic Advances in Medical Oncology
|
July 27, 2011
Targeting the Hedgehog pathway in cancer
Sachin Gupta, Naoko Takebe, Patricia Lorusso
Journal for Immunotherapy of Cancer
|
July 11, 2024
A crisis in clinical research
David S Hong, Patricia LoRusso, Mario Sznol
BMJ Case Reports
|
August 1, 2025
PALB2 c.3106G>C (p.Val1036Leu) in a familial cancer setting suggesting potential pathogenicity
Philippos Apolinario Costa, Nicole Hardy, Patricia LoRusso
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
April 19, 2011
Validation and implementation of a liquid chromatography/tandem mass spectrometry assay for quantitation of the total and unbound RO4929097, a γ-secretase inhibitor targeting Notch signaling, in human plasma
Jianmei Wu, Richard Wiegand, Patricia LoRusso, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 21, 2015
Achievements and challenges of molecular targeted therapy in melanoma
Ryan Sullivan, Patricia LoRusso, Scott Boerner, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
November 6, 2013
A stable isotope-labeled internal standard is essential for correcting for the interindividual variability in the recovery of lapatinib from cancer patient plasma in quantitative LC-MS/MS analysis
Jianmei Wu, Richard Wiegand, Patricia LoRusso, et al.
Current Drug Targets
|
July 23, 2011
Vascular disrupting agents (VDA) in oncology: advancing towards new therapeutic paradigms in the clinic
Matthew A Spear, Patricia LoRusso, Alain Mita, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
December 17, 2009
Simultaneous determination of ABT-888, a poly (ADP-ribose) polymerase inhibitor, and its metabolite in human plasma by liquid chromatography/tandem mass spectrometry
Richard Wiegand, Jianmei Wu, Xianyi Sha, et al.
Page
of 17
Search research articles
Search
Showing results (1-10 of 164) with videos related to
Sort By:
Page
of 17
Oncology (Williston Park, N.Y.)
|
March 28, 2009
Toward evidence-based management of the dermatologic effects of EGFR inhibitors
Patricia LoRusso
Targeted Oncology
|
May 7, 2011
Targeting phosphatidylinositol 3 kinase (PI3K)-Akt beyond rapalogs
Shin Ogita, Patricia Lorusso
Therapeutic Advances in Medical Oncology
|
July 27, 2011
Targeting the Hedgehog pathway in cancer
Sachin Gupta, Naoko Takebe, Patricia Lorusso
Journal for Immunotherapy of Cancer
|
July 11, 2024
A crisis in clinical research
David S Hong, Patricia LoRusso, Mario Sznol
BMJ Case Reports
|
August 1, 2025
PALB2 c.3106G>C (p.Val1036Leu) in a familial cancer setting suggesting potential pathogenicity
Philippos Apolinario Costa, Nicole Hardy, Patricia LoRusso
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
April 19, 2011
Validation and implementation of a liquid chromatography/tandem mass spectrometry assay for quantitation of the total and unbound RO4929097, a γ-secretase inhibitor targeting Notch signaling, in human plasma
Jianmei Wu, Richard Wiegand, Patricia LoRusso, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 21, 2015
Achievements and challenges of molecular targeted therapy in melanoma
Ryan Sullivan, Patricia LoRusso, Scott Boerner, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
November 6, 2013
A stable isotope-labeled internal standard is essential for correcting for the interindividual variability in the recovery of lapatinib from cancer patient plasma in quantitative LC-MS/MS analysis
Jianmei Wu, Richard Wiegand, Patricia LoRusso, et al.
Current Drug Targets
|
July 23, 2011
Vascular disrupting agents (VDA) in oncology: advancing towards new therapeutic paradigms in the clinic
Matthew A Spear, Patricia LoRusso, Alain Mita, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
December 17, 2009
Simultaneous determination of ABT-888, a poly (ADP-ribose) polymerase inhibitor, and its metabolite in human plasma by liquid chromatography/tandem mass spectrometry
Richard Wiegand, Jianmei Wu, Xianyi Sha, et al.
Page
of 17